These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

140 related articles for article (PubMed ID: 12180846)

  • 21. Evidence for synergy between sarcomeres and fibroblasts in an in vitro model of myocardial reverse remodeling.
    Shen S; Sewanan LR; Campbell SG
    J Mol Cell Cardiol; 2021 Sep; 158():11-25. PubMed ID: 33992697
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Human Engineered Heart Tissue: Analysis of Contractile Force.
    Mannhardt I; Breckwoldt K; Letuffe-Brenière D; Schaaf S; Schulz H; Neuber C; Benzin A; Werner T; Eder A; Schulze T; Klampe B; Christ T; Hirt MN; Huebner N; Moretti A; Eschenhagen T; Hansen A
    Stem Cell Reports; 2016 Jul; 7(1):29-42. PubMed ID: 27211213
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Miniaturized engineered heart tissues from hiPSC-derived triple cell type co-cultures to study human cardiac function.
    Windt LM; Wiendels M; Dostanić M; Bellin M; Sarro PM; Mastrangeli M; Mummery CL; van Meer BJ
    Biochem Biophys Res Commun; 2023 Nov; 681():200-211. PubMed ID: 37783118
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Paradoxical effects on force generation after efficient β1-adrenoceptor knockdown in reconstituted heart tissue.
    Neuber C; Müller OJ; Hansen FC; Eder A; Witten A; Rühle F; Stoll M; Katus HA; Eschenhagen T; El-Armouche A
    J Pharmacol Exp Ther; 2014 Apr; 349(1):39-46. PubMed ID: 24431469
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Long-term contractile activity and thyroid hormone supplementation produce engineered rat myocardium with adult-like structure and function.
    Jackman C; Li H; Bursac N
    Acta Biomater; 2018 Sep; 78():98-110. PubMed ID: 30086384
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Myocardial engineering in vivo: formation and characterization of contractile, vascularized three-dimensional cardiac tissue.
    Birla RK; Borschel GH; Dennis RG; Brown DL
    Tissue Eng; 2005; 11(5-6):803-13. PubMed ID: 15998220
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Cardiac tissue engineering in an in vivo vascularized chamber.
    Morritt AN; Bortolotto SK; Dilley RJ; Han X; Kompa AR; McCombe D; Wright CE; Itescu S; Angus JA; Morrison WA
    Circulation; 2007 Jan; 115(3):353-60. PubMed ID: 17200440
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Force characteristics of in vivo tissue-engineered myocardial constructs using varying cell seeding densities.
    Birla R; Dhawan V; Huang YC; Lytle I; Tiranathanagul K; Brown D
    Artif Organs; 2008 Sep; 32(9):684-91. PubMed ID: 18684210
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Protection by the NO-Donor SNAP and BNP against Hypoxia/Reoxygenation in Rat Engineered Heart Tissue.
    Görbe A; Eder A; Varga ZV; Pálóczi J; Hansen A; Ferdinandy P; Eschenhagen T
    PLoS One; 2015; 10(7):e0132186. PubMed ID: 26147889
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Piezo-bending actuators for isometric or auxotonic contraction analysis of engineered heart tissue.
    Mannhardt I; Warncke C; Trieu HK; Müller J; Eschenhagen T
    J Tissue Eng Regen Med; 2019 Jan; 13(1):3-11. PubMed ID: 30334614
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Three-dimensional reconstitution of embryonic cardiomyocytes in a collagen matrix: a new heart muscle model system.
    Eschenhagen T; Fink C; Remmers U; Scholz H; Wattchow J; Weil J; Zimmermann W; Dohmen HH; Schäfer H; Bishopric N; Wakatsuki T; Elson EL
    FASEB J; 1997 Jul; 11(8):683-94. PubMed ID: 9240969
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Mavacamten preserves length-dependent contractility and improves diastolic function in human engineered heart tissue.
    Sewanan LR; Shen S; Campbell SG
    Am J Physiol Heart Circ Physiol; 2021 Mar; 320(3):H1112-H1123. PubMed ID: 33449850
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Engineered heart tissue: a novel tool to study the ischemic changes of the heart in vitro.
    Katare RG; Ando M; Kakinuma Y; Sato T
    PLoS One; 2010 Feb; 5(2):e9275. PubMed ID: 20174664
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Dynamic Control of Contractile Force in Engineered Heart Tissue.
    Li H; Sundaram S; Hu R; Lou L; Sanchez F; McDonald W; Agarwal A; Chen CS; Bifano TG
    IEEE Trans Biomed Eng; 2023 Jul; 70(7):2237-2245. PubMed ID: 37021994
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Engineered heart tissue grafts improve systolic and diastolic function in infarcted rat hearts.
    Zimmermann WH; Melnychenko I; Wasmeier G; Didié M; Naito H; Nixdorff U; Hess A; Budinsky L; Brune K; Michaelis B; Dhein S; Schwoerer A; Ehmke H; Eschenhagen T
    Nat Med; 2006 Apr; 12(4):452-8. PubMed ID: 16582915
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Distribution and characteristics of telocytes as nurse cells in the architectural organization of engineered heart tissues.
    Zhou J; Wang Y; Zhu P; Sun H; Mou Y; Duan C; Yao A; Lv S; Wang C
    Sci China Life Sci; 2014 Feb; 57(2):241-7. PubMed ID: 24430556
    [TBL] [Abstract][Full Text] [Related]  

  • 37. A data-driven computational model for engineered cardiac microtissues.
    Jilberto J; DePalma SJ; Lo J; Kobeissi H; Quach L; Lejeune E; Baker BM; Nordsletten D
    Acta Biomater; 2023 Dec; 172():123-134. PubMed ID: 37879587
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Endothelial cell coculture within tissue-engineered cardiomyocyte sheets enhances neovascularization and improves cardiac function of ischemic hearts.
    Sekine H; Shimizu T; Hobo K; Sekiya S; Yang J; Yamato M; Kurosawa H; Kobayashi E; Okano T
    Circulation; 2008 Sep; 118(14 Suppl):S145-52. PubMed ID: 18824746
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Contractile work directly modulates mitochondrial protein levels in human engineered heart tissues.
    Ng R; Sewanan LR; Brill AL; Stankey P; Li X; Qyang Y; Ehrlich BE; Campbell SG
    Am J Physiol Heart Circ Physiol; 2020 Jun; 318(6):H1516-H1524. PubMed ID: 32383992
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Mechanism underlying the reduced positive inotropic effects of the phosphodiesterase III inhibitors pimobendan, adibendan and saterinone in failing as compared to nonfailing human cardiac muscle preparations.
    von der Leyen H; Mende U; Meyer W; Neumann J; Nose M; Schmitz W; Scholz H; Starbatty J; Stein B; Wenzlaff H
    Naunyn Schmiedebergs Arch Pharmacol; 1991 Jul; 344(1):90-100. PubMed ID: 1723153
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.